For example, well-established markers, such as estrogen receptor (ER) and Human Epidermal Growth Factor Receptor-type 2 (HER2/neu), are used to differentiate breast cancer types, but the expression of these receptors can change between primary tumor and CTCs [17,18]. Here, ERBB2 is linked to breast carcinoma.